377 related articles for article (PubMed ID: 32386868)
21. Cryopreservation of a mother's oocytes for possible future use by her daughter with Turner syndrome: case report.
Gidoni YS; Takefman J; Holzer HE; Elizur SE; Son WY; Chian RC; Tan SL
Fertil Steril; 2008 Nov; 90(5):2008.e9-12. PubMed ID: 18692829
[TBL] [Abstract][Full Text] [Related]
22. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
[TBL] [Abstract][Full Text] [Related]
23. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
[TBL] [Abstract][Full Text] [Related]
24. Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
Kummer NE; Feinn RS; Griffin DW; Nulsen JC; Benadiva CA; Engmann LL
Hum Reprod; 2013 Jan; 28(1):152-9. PubMed ID: 23077235
[TBL] [Abstract][Full Text] [Related]
25. Why are some patients with 45,X Turner syndrome fertile? A young girl with classical 45,X Turner syndrome and a cryptic mosaicism in the ovary.
Nadesapillai S; van der Velden J; Smeets D; van de Zande G; Braat D; Fleischer K; Peek R
Fertil Steril; 2021 May; 115(5):1280-1287. PubMed ID: 33342535
[TBL] [Abstract][Full Text] [Related]
26. Laparoscopic oocyte retrieval for fertility preservation in a patient with squamous cell carcinoma of the vagina.
Giampaolino P; Mercorio A; Serafino P; Iorio GG; Buonfantino C; Bifulco G; Di Spiezio Sardo A; Carugno J; Alviggi C
Fertil Steril; 2023 Sep; 120(3 Pt 2):701-702. PubMed ID: 37302780
[TBL] [Abstract][Full Text] [Related]
27. A "freeze-all" embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome?
Ortega-Hrepich C; Stoop D; Guzmán L; Van Landuyt L; Tournaye H; Smitz J; De Vos M
Fertil Steril; 2013 Oct; 100(4):1002-7. PubMed ID: 23850301
[TBL] [Abstract][Full Text] [Related]
28. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
29. Fertility Preservation in Women with Turner Syndrome: A Comprehensive Review and Practical Guidelines.
Oktay K; Bedoschi G; Berkowitz K; Bronson R; Kashani B; McGovern P; Pal L; Quinn G; Rubin K
J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):409-416. PubMed ID: 26485320
[TBL] [Abstract][Full Text] [Related]
30. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
[TBL] [Abstract][Full Text] [Related]
31. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z
Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of fertility preservation in young females with Turner syndrome.
Lau NM; Huang JY; MacDonald S; Elizur S; Gidoni Y; Holzer H; Chian RC; Tulandi T; Tan SL
Reprod Biomed Online; 2009 Feb; 18(2):290-5. PubMed ID: 19192353
[TBL] [Abstract][Full Text] [Related]
33. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
[TBL] [Abstract][Full Text] [Related]
34. Impact of extent and biochemical parameters of lymphoma on fertility preservation outcome.
Volodarsky-Perel A; Tulandi T; Son WY; Khojah M; Buckett W
Fertil Steril; 2020 Feb; 113(2):400-407.e1. PubMed ID: 32106993
[TBL] [Abstract][Full Text] [Related]
35. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
[TBL] [Abstract][Full Text] [Related]
36. Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency.
Gayete-Lafuente S; Turan V; Oktay KH
J Assist Reprod Genet; 2023 Dec; 40(12):2777-2785. PubMed ID: 37715873
[TBL] [Abstract][Full Text] [Related]
37. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
38. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
Huber M; Hadziosmanovic N; Berglund L; Holte J
Fertil Steril; 2013 Nov; 100(5):1270-6. PubMed ID: 23931964
[TBL] [Abstract][Full Text] [Related]
39. Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study.
Weiss A; Neril R; Geslevich J; Lavee M; Beck-Fruchter R; Golan J; Shalev E
Fertil Steril; 2014 Aug; 102(2):419-23. PubMed ID: 24880653
[TBL] [Abstract][Full Text] [Related]
40. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
